We are live on !
Find out more
Simplify Asset Management Portfolio holdings
AUM
$7.19B
Turnover
25.77%
1-Year Est. Return
6.88%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$7.19B
AUM Growth
+$670M
(+10%)
Cap. Flow
+$436M
Cap. Flow % of AUM
Cap. Flow %
6.07%
Top 10 Holdings %
Top 10 Hldgs %
91.65%
Holding
163
New
20
Increased
70
Reduced
37
Closed
22
Avg Time Held
Equity + Options
1.2
years
Top 10 Avg Time Held
Equity + Options
1.5
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simplify Government Money Market ETF
SBIL
|
+$311M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$93.2M |
| 3 |
UnitedHealth
UNH
|
+$14.6M |
| 4 |
Simplify China A Shares PLUS Income ETF
CAS
|
+$11.6M |
| 5 |
PureCycle Technologies
PCT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$36.1M |
| 2 |
Simplify Short Term Treasury Futures Strategy ETF
TUA
|
+$14.9M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$8.67M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$8.42M |
| 5 |
Align Technology
ALGN
|
+$6.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.55% |
| 2 | Healthcare | 5.05% |
| 3 | Energy | 0.44% |
| 4 | Industrials | 0.38% |
| 5 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Benitec Biopharma
BNTC
$292M
| $13.5M | 0.19% |
1,005,557
+443,315
| +79% | +$5.26M |
2024 Q2
8 quarters
|
|
|
27
Simplify China A Shares PLUS Income ETF
CAS
$11.4M
| $12.4M | 0.17% |
+428,078
| New | +$11.6M |
2026 Q2
0 quarters
|
|
28
Thermo Fisher Scientific
TMO
$251B
| $11.6M | 0.16% |
23,079
+5,670
| +33% | +$2.72M |
2021 Q4
18 quarters
|
|
|
29
Align Technology
ALGN
$10.6B
| $11.3M | 0.16% |
66,847
-40,050
| -37% | -$6.95M |
2025 Q4
2 quarters
|
|
30
10x Genomics
TXG
$9.11B
| $11.2M | 0.16% |
292,938
-61,765
| -17% | -$1.62M |
2025 Q4
2 quarters
|
|
31
Quest Diagnostics
DGX
$25.9B
| $10.5M | 0.15% |
+49,715
| New | +$9.8M |
2026 Q2
0 quarters
|
|
32
CALL
NVIDIA
NVDA
$5.24T
| $10.4M | 0.14% |
+52,000
| New | +$10.7M |
2026 Q2
0 quarters
|
|
33
Gilead Sciences
GILD
$190B
| $10.3M | 0.14% |
81,325
+19,980
| +33% | +$2.63M |
2024 Q3
7 quarters
|
|
34
Elevance Health
ELV
$93.3B
| $9.9M | 0.14% |
+25,577
| New | +$9.49M |
2026 Q2
0 quarters
|
|
35
Achieve Life Sciences
ACHV
$682M
| $9.35M | 0.13% |
1,432,105
+247,593
| +21% | +$1.18M |
2024 Q1
9 quarters
|
|
36
Danaher
DHR
$158B
| $8.16M | 0.11% |
42,834
+10,530
| +33% | +$1.91M |
2024 Q1
9 quarters
|
|
37
Amgen
AMGN
$230B
| $7.6M | 0.11% |
20,974
+5,130
| +32% | +$1.76M |
2025 Q4
2 quarters
|
|
38
CVS Health
CVS
$119B
| $7.35M | 0.1% |
71,090
+17,077
| +32% | +$1.52M |
2024 Q4
6 quarters
|
|
39
AstraZeneca
AZN
$254B
| $6.48M | 0.09% |
34,188
+8,370
| +32% | +$1.57M |
2025 Q1
5 quarters
|
|
40
Cardinal Health
CAH
$58.5B
| $6.38M | 0.09% |
+26,924
| New | +$5.6M |
2026 Q2
0 quarters
|
|
41
EyePoint Inc
EYPT
$37.9M
| $5.72M | 0.08% |
400,044
+73,902
| +23% | +$989K |
2025 Q1
5 quarters
|
|
42
Establishment Labs
ESTA
$1.74B
| $5.19M | 0.07% |
60,540
+7,531
| +14% | +$541K |
2025 Q3
3 quarters
|
|
43
Vertex Pharmaceuticals
VRTX
$127B
| $5.19M | 0.07% |
10,456
+2,520
| +32% | +$1.12M |
2024 Q4
6 quarters
|
|
44
Milestone Pharmaceuticals
MIST
$87.2M
| $4.49M | 0.06% |
3,349,379
+1,842,974
| +122% | +$2.95M |
2025 Q1
5 quarters
|
|
45
Tesla
TSLA
$1.45T
| $4.47M | 0.06% |
10,621
-473
| -4% | -$188K |
2020 Q4
22 quarters
|
|
46
VanEck Bitcoin Trust
HODL
$1.37B
| $4.39M | 0.06% |
264,427
+55,276
| +26% | +$1.12M |
2025 Q1
5 quarters
|
|
47
Guardant Health
GH
$21.2B
| $4.14M | 0.06% |
27,571
+6,750
| +32% | +$734K |
2025 Q2
4 quarters
|
|
48
Rithm Capital
RITM
$4.71B
| $3.86M | 0.05% |
411,593
+75,000
| +22% | +$715K |
2024 Q1
9 quarters
|
|
49
Delcath Systems
DCTH
$499M
| $3.33M | 0.05% |
264,770
+3,644
| +1% | +$40.3K |
2024 Q4
6 quarters
|
|
50
GE HealthCare
GEHC
$31.5B
| $3.33M | 0.05% |
52,040
+12,780
| +33% | +$840K |
2025 Q2
4 quarters
|
|
Similar funds
SAM
Simplify Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Simplify Asset Management held 163 positions worth $7.19B, up 10% from $6.52B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Simplify Asset Management deployed $436M of net new capital in Q2 2026, opening 20 new positions and adding to 70 existing holdings. Its largest new stake was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $36.1M trimmed.
- Simplify Asset Management's largest Q2 2026 buy was Simplify China A Shares PLUS Income ETF: 428,078 shares worth $12.4M.
- Simplify Asset Management added most to Simplify Government Money Market ETF in Q2 2026, an estimated $311M increase.
- Simplify Asset Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $36.1M.
- Simplify Asset Management fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $8.42M.
- Simplify Asset Management's ten largest holdings make up 92% of its $7.19B portfolio in Q2 2026.
- Simplify Asset Management opened 20 new positions and closed 22 in Q2 2026.
- Simplify Asset Management's portfolio value rose 10% quarter-over-quarter to $7.19B.
Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.